Canaccord Genuity Raises Price Target on Teva Pharma (TEVA) Following Announced Acquisition of Allergan Generics
Go back to Canaccord Genuity Raises Price Target on Teva Pharma (TEVA) Following Announced Acquisition of Allergan Generics| TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) | Delayed: 33.28 +1.08 (3.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.20 | 52 Week High | $66.55 | |||
| Open | $32.14 | 52 Week Low | $37.82 | |||
| Day High | $33.30 | P/E | N/A | |||
| Day Low | $32.12 | EPS | $0.00 | |||
| Volume | 3,234,058 | |||||
